Free Trial

RH (RH) Stock Forecast & Price Target

RH logo
$342.19 +5.39 (+1.60%)
(As of 11:15 AM ET)

RH - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
6
Buy
7

Based on 15 Wall Street analysts who have issued ratings for RH in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 2 have given a sell rating, 6 have given a hold rating, and 7 have given a buy rating for RH.

Consensus Price Target

$326.14
-4.69% Downside
According to the 15 analysts' twelve-month price targets for RH, the average price target is $326.14. The highest price target for RH is $430.00, while the lowest price target for RH is $226.00. The average price target represents a forecasted downside of -4.69% from the current price of $342.19.
Get the Latest News and Ratings for RH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for RH and its competitors.

Sign Up

RH Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
2 Buy rating(s)
Hold
6 Hold rating(s)
7 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$326.14$331.77$310.79$319.87
Forecasted Upside-4.69% Downside-1.51% Downside9.74% Upside18.50% Upside
Consensus Rating
Hold
Hold
Hold
Hold

RH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

RH Stock vs. The Competition

TypeRHConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.33
2.47
2.50
Consensus RatingHoldHoldModerate Buy
Predicted Upside-3.16% Downside40.78% Upside9.81% Upside
News Sentiment Rating
Neutral News

See Recent RH News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/13/2024BNP Paribas
3 of 5 stars
S. Mcmanus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Underperform$253.00-24.13%
10/21/2024Wedbush
4 of 5 stars
S. Basham
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$310.00 ➝ $430.00+21.29%
9/16/2024JPMorgan Chase & Co.
3 of 5 stars
 Lower TargetOverweight ➝ Overweight$345.00 ➝ $338.00-0.44%
9/16/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$340.00 ➝ $320.00-3.92%
9/16/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$315.00 ➝ $375.00+16.69%
9/16/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$230.00 ➝ $320.00-0.42%
9/13/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$340.00 ➝ $355.00+10.29%
9/13/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$310.00 ➝ $359.00+12.60%
9/13/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$325.00 ➝ $350.00+12.37%
9/13/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$325.00 ➝ $350.00+11.91%
9/13/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$275.00 ➝ $290.00+13.03%
9/13/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$300.00 ➝ $310.00+20.82%
9/10/2024Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform$290.00 ➝ $290.00+20.01%
6/17/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSell ➝ Sell$264.00 ➝ $226.00-2.54%
4/1/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform
9/8/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$350.00 ➝ $340.00-7.76%
6/29/202351job
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
3/30/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$375.00 ➝ $325.00+32.27%
3/30/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$298.00 ➝ $227.00-7.61%
12/12/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$350.00 ➝ $320.00+24.33%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:34 AM ET.


RH Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for RH is $326.14, with a high forecast of $430.00 and a low forecast of $226.00.

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for RH in the last year. There are currently 2 sell ratings, 6 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" RH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RH, but not buy additional shares or sell existing shares.

According to analysts, RH's stock has a predicted downside of -4.69% based on their 12-month stock forecasts.

Over the previous 90 days, RH's stock had 1 upgrade by analysts.

Analysts like RH less than other "consumer staples" companies. The consensus rating score for RH is 2.33 while the average consensus rating score for "consumer staples" companies is 2.47. Learn more on how RH compares to other companies.


This page (NYSE:RH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners